ROLDITAMIG DEUDERUXTECAN
UNII 7FWF3FB9ZY

Substance Identification & Data

This profile provides standardized clinical and technical data for Rolditamig Deuderuxtecan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7FWF3FB9ZY.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3038136-63-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

7FWF3FB9ZY

CAS Registry Number

3038136-63-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ROLDITAMIG DEUDERUXTECAN

Official standardized name for this substance within the FDA UNII nomenclature system.

INN ID

13866

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rolditamig Deuderuxtecan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ROLDITAMIG DEUDERUXTECAN

Common Names & Synonyms

IMMUNOGLOBULIN (H-GAMMA1_L-KAPPA)_SCFVHK-G1(H-CH2-CH3), ANTI-(HOMO SAPIENS ERBB2 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-2, EPIDERMAL GROWTH FACTOR RECEPTOR 2, EGFR2, HER2, HER-2, P185C-ERBB2, NEU, CD340) EXTRACELLULAR DOMAINS 2 AND 4), HUMANIZED MONOCLONAL ANTIBODY, BIPARATOPIC, CONJUGATED ON AN AVERAGE OF SIX CYSTEINYL RESIDUES TO DEUDERUXTECAN, COMPRISING A CLEAVABLE LINKER AND A CAMPTOTHECIN DERIVATIVE (ROLDITAMIG DEUDERUXTECAN)

IMMUNOGLOBULIN, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR HER2 EXTRACELLULAR DOMAIN 4) (HUMAN-MUS MUSCULUS MONOCLONAL RHUMAB 2C4 SINGLE-CHAIN VARIABLE FRAGMENT VH-(GGGGS)4-VL) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (5-SERINE,139-CYSTEINE,150-TRYPTOPHAN) (HUMAN .GAMMA.1-CHAIN HINGE-CH2-CH3 FRAGMENT), (387->351')-DISULFIDE WITH IMMUNOGLOBULIN G1 (216-LYSINE,351-CYSTEINE,368-SERINE,370-ALANINE,409-VALINE,437-ARGININE,438-PHENYLALANINE) ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR HER2 EXTRACELLULAR DOMAIN 2) (HUMAN-MUS MUSCULUS MONOCLONAL HUM-AB4D5-8 .GAMMA.1-CHAIN), COMPLEX WITH (HUMAN-MUS MUSCULUS MONOCLONAL HUM-AB4D5-8 .KAPPA.-CHAIN), 214'',222',228',231',259,262-HEXAKIS(THIOETHER) WITH N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)GLYCYLGLYCYL-L-PHENYLALANYL-N-((2-(((1S,9S)-9-ETHYL-5-FLUORO-2,3,9,10,13,15-HEXAHYDRO-9-HYDROXY-4-METHYL-10,13-DIOXO-1H,12H-BENZO(DE)PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLIN-1-YL)AMINO)-2-OXOETHOXY-1,1-D2)METHYL)GLYCINAMIDE

ROLDITAMIG DEUDERUXTECAN [INN]

External Clinical & Regulatory Resources

Previous UNII7FW70TQ4GS

Next UNII7FWM33RU3Y